Biogen (BIIB) 30-day option implied volatility at 43

June 24, 2021 10:47 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Biogen (NASDAQ: BIIB) 30-day option implied volatility is at 43; compared to its 52-week range of 28 to 121 after Eli Lilly (LLY) receives therapy designation for donanemab from FDA.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Options, FDA